Inventiva (IVA) reported Q2 2026 earnings and revenue that surpassed analyst estimates. Despite the strong financial performance, the company's stock experienced a decline as investors remained cautious.
Inventiva Exceeds Q2 Estimates; Shares Decline Amid Investor Caution
InventivaEarningsBiotechnologyQ2 2026


